Ridde Valéry auteur aut IRD Ba M. F. auteur aut IRD Gaye I. auteur aut IRD Diallo A. I. auteur aut IRD Bonnet Emmanuel auteur aut IRD Faye A. auteur aut IRD text journalArticle eng text/pdf reformatted digital access This research aims to understand the level and determinants of people's willingness to participate in a vaccine trial for COVID-19 in Senegal. We conducted a telephone survey among a marginal quota sample of 607 people over 18 years of age. Only 44.3% of the participants wanted to participate in a vaccine trial for COVID-19, with females intending to participate more than males (AOR = 1.82, 95% CI [1.22-2.72]). Participants who intended to be vaccinated against COVID-19 (AOR = 6.48, 95% CI [4.12-10.4]) and who thought that being infected with the coronavirus would have a significant impact on their health (AOR = 2.34, 95% CI [1.57, 3.51]) were more likely to agree to take part in the COVID-19 vaccine trial. Confidence in the vaccine, health personnel, and the government in the fight against the pandemic are key factors in participants' willingness to participate in a vaccine trial in Senegal. specialized Vaccine trial COVID-19 Senegal acceptability participation SENEGAL 052 050 056 17 11 3907-3912 2021 2164-5515 https://www.documentation.ird.fr/hor/fdi:010082596 10.1080/21645515.2021.1951097 2164-5515 [F B010082596] https://www.documentation.ird.fr/hor/fdi:010082596 https://horizon.documentation.ird.fr/exl-doc/pleins_textes/2022-09/010082596.pdf IRD - Base Horizon / Pleins textes 2021-09-17 2025-02-24 fdi:010082596 fre